CARDIFF LEXINGTON CORPORATION

CDIX ·Healthcare, Medical Care Facilities, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
Revenue $11.5M $8.3M $11.9M $10.7M $9.9M $3.5M $3.7M
Cost of Revenue $4.3M $3.8M $3.6M $4.1M $3.8M $1.7M $1.7M
Gross Profit $7.2M $4.4M $8.3M $6.6M $6.1M $1.8M $2.0M
Gross Margin 62.5% 53.5% 70.0% 62.0% 61.9% 51.7% 55.1%
Operating Expenses
Research & Development
SG&A Expense $5.3M $4.1M $3.1M $2.7M $4.4M $3.6M $3.3M
Operating Income $1.1M $-193.5K $5.2M $3.9M $1.7M $-1.8M $-1.3M
Operating Margin 9.5% -2.3% 43.8% 36.5% 16.8% -52.2% -34.3%
Interest Expense $439.6K $452.9K $143.7K $489.3K
Pretax Income $-5.7M $-3.2M $3.1M $-3.3M $-303.6K $-2.9M $-6.0M
Income Tax Expense $0
Net Income $-5.5M $-3.3M $3.0M $-5.4M $666.3K $-2.8M $-7.2M
Net Margin -47.7% -39.9% 25.5% -50.8% 6.7% -82.2% -193.7%
EPS (Basic) $-0.98 $-0.55 $0.31 $-0.66 $0.00 $0.00 $0.00
EPS (Diluted) $-0.98 $-0.55 $0.30 $-0.66 $0.00 $0.00 $0.00
Shares Outstanding (Basic) 15.2M 6.9M 7.6M 7.3M 665.43B 195.10B 195.22B 196.50B
Shares Outstanding (Diluted) 15.2M 8.5M 7.6M 7.6M 8.9M 195.10B 195.22B 196.50B
Dividends Per Share
← Newer Page 1 of 4 Older →